The CMIL team has received $2,084,185 in funding from a National Institutes of Health (NIH) OT2 award to develop an AI-based, ethically grounded, multimodal framework for screening, diagnosing, and caring for patients with Chronic Kidney Disease (CKD).
The project will leverage data from 200,000 CKD patients, integrating electronic medical records, radiology, pathology, and spatial omics to support earlier detection, more accurate diagnosis, and improved patient care.
As outlined in the original RFA, this OT2 mechanism is eligible for extension and supplementation into Year 2, contingent upon the successful completion of Year 1 milestones.